Copy Link Print Information

Exendin(9-39) amide acetate

(Synonyms: Avexitide acetate)
46 Cited Publications
Customer Review

Based on 46 publication(s) in Google Scholar

Exendin (9-39) amide acetate (Avexitide acetate) is a competitive GLP-1R antagonist. Exendin (9-39) amide acetate blocks the Semaglutide (HY-114118)-induced increase in insulin secretion and also attenuates the hypoglycemic effect of Semaglutide. Exendin (9-39) amide acetate abolishes the islet-protective effect of Liraglutide. Exendin (9-39) amide acetate can be used in research on type 2 diabetes and type 1 diabetes.

For research use only. We do not sell to patients.

  • Purity : 99.41%
  • CAS No.: 2051593-46-3
  • Formula: C149H234N40O47S·xC2HF3O2
  • Molecular Weight:3369.76 (free base)
  • Storage:

    Sealed storage, away from moisture.

    Powder   -80°C, 2 years , -20°C, 1 year

    * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

  • Exendin(9-39) amide acetate Chemical Structure
    Exendin(9-39) amide acetate Chemical Structure
  • Experimental Validation Results for Exendin(9-39) amide acetate
  • Experimental Validation Results for Exendin(9-39) amide acetate
  • Experimental Validation Results for Exendin(9-39) amide acetate
  • Experimental Validation Results for Exendin(9-39) amide acetate
  • Experimental Validation Results for Exendin(9-39) amide acetate
  • Experimental Validation Results for Exendin(9-39) amide acetate
CAS No.: 2051593-46-3
Size
Price
Stock
Quantity
Amount: USD 0.00
Please select quantity
or
or

* Please select Quantity before adding items.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Other Forms of Exendin(9-39) amide acetate:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Find Your Local Distributor Your local distributor: Hycultec GmbHHycultec
  • Biological Activity
  • Chemical Information
  • Solvent & Solubility
  • Protocols
  • Purity & Documentation
  • References
  • Help & FAQs
Top Publications Citing

Use of MCE Products

Publications Citing Use of MedChemExpress (MCE) Exendin(9-39) amide acetate

More
Customer Validation & Images
WBBio/Physico-chemical AssayIF
  • Bio/Physico-chemical Assay
  • WB
  • IF
  • WB
  • IF
  • Bio/Physico-chemical Assay

Keywords

MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Sign In
Register
Sign in to MedChemExpress
Register New Account

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • Exendin(9-39) amide acetate Chemical Structure
    Exendin(9-39) amide acetate Chemical Structure
    1/16
  • 1/16

    Exendin(9-39) amide acetate purchased from MedChemExpress. Usage Cited in: Biomed Pharmacother. 2024 Sep:178:117202. [Abstract]

    Customer Validation
     Idebenone augmented insulin secre tion at 11.1 mM glucose (p<0.001), and the insulinotropic action of idebenone was markedly reversed by Exendin (9− 39).

  • 1/16

    Exendin(9-39) amide acetate purchased from MedChemExpress. Usage Cited in: J Headache Pain. 2021 Jul 29;22(1):86. [Abstract]

    Customer Validation
     Western blots showing the alteration of CGRP protein levels in the TNC treated with liraglutide and Exendin (9–39) (50 μg/kg; i.p.; 16 days).

  • 1/16

    Exendin(9-39) amide acetate purchased from MedChemExpress. Usage Cited in: J Headache Pain. 2021 Jul 29;22(1):86. [Abstract]

    Customer Validation
     The density of CGRP-immunoreactive fibres in the TNC was increased in the CM and Exendin (9–39) (50 μg/kg; i.p.; 16 days) treated (CM + Exe(9–39)) groups compared with the sham group.

  • 1/16

    Exendin(9-39) amide acetate purchased from MedChemExpress. Usage Cited in: J Headache Pain. 2021 Jul 29;22(1):86. [Abstract]

    Customer Validation
     Western blots showing the changes in c-fos protein expression in the TNC following liraglutide and Exendin (9–39) (50 μg/kg; i.p.; 16 days) administration.

  • 1/16

    Exendin(9-39) amide acetate purchased from MedChemExpress. Usage Cited in: J Headache Pain. 2021 Jul 29;22(1):86. [Abstract]

    Customer Validation
     The immunofluorescence results for c-fos in the TNC showed that the number of c-fos immunoreactive cells in the Exendin (9–39) (50 μg/kg; i.p.; 16 days) treated group (CM + Exe(9–39), 72.33 ± 14.95) was higher than that of sham group (39.83 ± 13.23).

  • 1/16

    Exendin(9-39) amide acetate purchased from MedChemExpress. Usage Cited in: Br J Pharmacol. 2020 Aug;177(15):3389-3402. [Abstract]

    Customer Validation
     The addition of Exendin‐9–39 (10 nM, 20 nM) eliminated the effect of Exendin‐4 on NO levels.

  • Exendin(9-39) amide acetate